T

Topos Bio

AI-driven drug discovery for IDPs

Cellular Biologist

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USANo salary listedIn-person

About the Job

Requirements

  • Strong foundation in mammalian cell culture and cellular assay development.
  • Experience with disease-relevant cellular models.
  • Ability to troubleshoot complex biological systems and optimize experimental protocols.
  • A track record of productivity and effective collaboration.

Responsibilities

  • Develop and optimize mammalian cell-based assays for disordered protein targets.
  • Execute phenotypic and reporter-based screening campaigns to validate computational hits.
  • Characterize compound activity and support structure-activity relationship studies.
  • Collaborate with computational scientists to integrate experimental data with modeling workflows.
  • Establish robust assay protocols and quality control metrics.

Desired Qualifications

  • A PhD in cell and molecular biology with a focus on disease models.
  • Industry experience in drug discovery or biotechnology.
  • Experience with reporter assays and high-throughput screening platforms.
  • Familiarity with oncology, neurodegeneration, or metabolic disease models.
  • A track record of developing novel cellular assays or screening approaches.

About the Company

Topos Bio

AI-driven drug discovery for IDPs

Topos Bio builds an AI-enabled drug discovery platform that targets intrinsically disordered proteins (IDPs), which are linked to diseases like Alzheimer's, Parkinson's, and cancer. Its core product, Topos-1, generates conformational ensembles of IDPs and finds transient binding opportunities for small molecules, peptides, and degraders, with a wet-lab loop that validates and refines the AI models. The company differs from others by modeling protein dynamics instead of fixed structures and by combining physics, AI, and neuroscience, plus collaborating with Gladstone Institutes to modulate alpha-synuclein. Its goal is to rationally design therapeutics against IDPs—from neuroscience into oncology and metabolic diseases—through partnerships and a growing discovery pipeline.

Company size
11-50
Company stage
Seed
Total funding
$10.5M
Headquarters
San Francisco, CA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Topos Bio

See more jobs